Namenda

Allergan, Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 15, 2019
Approval ID: 710f523f-0158-4639-8ce7-57598247d48c
Products: 5 registered
Version: 17

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NAMENDA XR capsules safely and effectively. See full prescribing information for NAMENDA XR capsules. NAMENDA XR (memantine hydrochloride) extended - release capsules , for oral use Initial U.S. Approval: 2003

Quick Stats

Total Products5

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.